Perinatal outcomes of twenty-five human immunodeficiency virus-infected pregnant women: Hacettepe University experience

被引:3
|
作者
Inkaya, Ahmet Cagkan [1 ]
Orgul, Gokcen [2 ]
Halis, Nurhayat [2 ]
Alp, Sehnaz [1 ]
Kara, Ates [3 ]
Ozyuncu, Ozgur [2 ]
Yurdakok, Murat [4 ]
Unal, Serhat [1 ]
Beksac, M. Sinan [2 ]
机构
[1] Hacettepe Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Ankara, Turkey
[2] Hacettepe Univ, Dept Obstet & Gynecol, Div Perinatol, Fac Med, Ankara, Turkey
[3] Hacettepe Univ, Dept Pediat Infect Dis, Fac Med, Ankara, Turkey
[4] Hacettepe Univ, Dept Child Hlth & Dis, Fac Med, Ankara, Turkey
关键词
HIV; Pregnancy; antenatal care; Turkey; CHILD HIV TRANSMISSION; ANTIRETROVIRAL THERAPY; MOTHER; PREECLAMPSIA; PREVENTION; ZIDOVUDINE; DELIVERY; IRELAND; INFANT; RATES;
D O I
10.4274/jtgga.galenos.2019.2019.0033
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate perinatal outcomes in human immunodeficiency virus (HIV) infected pregnant women in Turkey. Material and Methods: Maternal characteristics, pregnancy complications, laboratory findings including HIV load, CD4 cell count, CD4/CD8 ratio, neonatal features and final HIV status of the baby were retrospectively analyzed. Results: The sample included 26 singleton pregnancies, from 25 HIV-infected women. The ethnicities were Turkish (n=18), East European (n=4), Asian (n=2) and African (n=2). The majority (76.9%) was aware of their HIV status before becoming pregnant. Four cases (15.3%) were diagnosed during pregnancy and two (7.8%) at the onset of labor. The results for median HIV viral load, CD4 count, and CD4/CD8 ratio at birth were 20 copies/mL (0-34 587), 577/mm(3) (115-977), and 0.7 (0.1-1.9), respectively. The HIV viral load rate was 5.5% in eighteen women taking anti-retroviral treatment. The rates of gestational diabetes mellitus, gestational hypertension, intrauterine growth restriction, and preterm delivery were 3.8%, 3.8%, 7.6%, and 8% (numbers are 1;1;2;2), respectively. The mean gestational week at birth was 38 weeks and mean birthweight is 2972 +/- 329 g. Two babies were congenitally infected with HIV (infection rate of 8.3%). There was one needle-related accident during surgery. Conclusion: Timely diagnosis of HIV infection during pregnancy is important for preventing mother to child transmission. HIV infected women may give birth to HIV negative babies with the help of a multidisciplinary team, composed of perinatology, infectious diseases, and pediatrics specialists.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [1] A retrospective analysis of adverse perinatal outcomes in human immunodeficiency virus-infected pregnant women
    Burke, Charlotte V.
    Tuuli, Methodius
    Basanta-Henry, Patrice
    Duong, Ninh
    Linay, Michael
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 80S - 80S
  • [2] Outcomes in human immunodeficiency virus-infected pregnant women treated with protease inhibitors
    Einstein, FH
    Wright, R
    Trentacoste, S
    Chazotte, C
    Merkatz, IR
    Bernstein, PS
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 24S - 24S
  • [3] Risk of Preeclampsia in Human Immunodeficiency Virus-Infected Pregnant Women
    Sansone, Matilde
    Sarno, Laura
    Saccone, Gabriele
    Berghella, Vincenzo
    Maruotti, Giuseppe Maria
    Migliucci, Annalisa
    Capone, Angela
    Martinelli, Pasquale
    OBSTETRICS AND GYNECOLOGY, 2016, 127 (06): : 1027 - 1032
  • [4] OBSTETRIC AND PERINATAL OUTCOME IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PREGNANT-WOMEN WITH AND WITHOUT OPIATE ADDICTION
    MAURI, A
    PICCIONE, E
    DEIANA, P
    VOLPE, A
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 58 (02) : 135 - 140
  • [5] Safety and Efficacy of Fosamprenavir in Human Immunodeficiency Virus-infected Pregnant Women
    Martorell, Claudia
    Theroux, Eileen
    Bermudez, Arlene
    Garb, Jane
    Kronschnabel, Debra
    Oie, Katrina
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 985 - 985
  • [6] TREATMENT OPTIONS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PREGNANT-WOMEN
    SPERLING, RS
    STRATTON, P
    OBSTETRICS AND GYNECOLOGY, 1992, 79 (03): : 443 - 448
  • [7] Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
    Unadkat, Jashvant D.
    Wara, Diane W.
    Hughes, Michael D.
    Mathias, Anita A.
    Holland, Diane T.
    Paul, Mary E.
    Connor, James
    Huang, Sharon
    Nguyen, Bach-Yen
    Watts, D. Heather
    Mofenson, Lynne M.
    Smith, Elizabeth
    Deutsch, Paul
    Kaiser, Kathleen A.
    Tuomala, Ruth E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 783 - 786
  • [8] Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
    McGowan, JP
    Crane, M
    Wiznia, AA
    Blum, S
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (05): : 641 - 646
  • [9] Codon 215 mutations in human immunodeficiency virus-infected pregnant women
    Kully, C
    Yerly, S
    Erb, P
    Kind, C
    Krautheim, A
    Perrin, L
    Rudin, C
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 705 - 708
  • [10] Global approach to human immunodeficiency virus-infected pregnant women: Experience at the Catholic University of the Sacred Heart, Rome, Italy - Reply
    Kass, NE
    Taylor, HA
    Anderson, JR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (03) : 516 - 517